Spatial metabolomics identifies distinct tumor-specific and stroma-specific subtypes in patients with lung squamous cell carcinoma
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Spatial metabolomics identifies distinct tumor-specific and stroma-specific subtypes in patients with lung squamous cell carcinoma
Authors
Keywords
-
Journal
npj Precision Oncology
Volume 7, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-02
DOI
10.1038/s41698-023-00434-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Spatial Metabolomics Identifies Distinct Tumor-Specific Subtypes in Gastric Cancer Patients
- (2022) Jun Wang et al. CLINICAL CANCER RESEARCH
- Spatial metabolomics for evaluating response to neoadjuvant therapy in non‐small cell lung cancer patients
- (2022) Jian Shen et al. Cancer Communications
- Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinoma
- (2021) Xiu-Shen Li et al. BMC CANCER
- Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
- (2021) Carl M. Gay et al. CANCER CELL
- A proteogenomic portrait of lung squamous cell carcinoma
- (2021) Shankha Satpathy et al. CELL
- Patterns of Carbon-Bound Exogenous Compounds in Patients with Lung Cancer and Association with Disease Pathophysiology
- (2021) Thomas Kunzke et al. CANCER RESEARCH
- Subtyping non-small cell lung cancer by histology-guided spatial metabolomics
- (2021) Judith Martha Neumann et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Lung Cancer 2020
- (2020) Brett C. Bade et al. CLINICS IN CHEST MEDICINE
- De novo discovery of metabolic heterogeneity with immunophenotype-guided imaging mass spectrometry
- (2020) Verena M. Prade et al. Molecular Metabolism
- Optimized Protocol for Metabolomic and Lipidomic Profiling in Formalin-Fixed Paraffin-Embedded Kidney Tissue by LC-MS
- (2020) Sylvia K. Neef et al. ANALYTICA CHIMICA ACTA
- Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH)
- (2020) Keith T. Flaherty et al. JOURNAL OF CLINICAL ONCOLOGY
- Development of an Immune-Related Risk Signature for Predicting Prognosis in Lung Squamous Cell Carcinoma
- (2020) Denggang Fu et al. Frontiers in Genetics
- Proteogenomic landscape of squamous cell lung cancer
- (2019) Paul A. Stewart et al. Nature Communications
- New aspects of amino acid metabolism in cancer
- (2019) Lisa Vettore et al. BRITISH JOURNAL OF CANCER
- Phenotype molding of stromal cells in the lung tumor microenvironment
- (2018) Diether Lambrechts et al. NATURE MEDICINE
- Classifying Non-Small Cell Lung Cancer by Status of Programmed Cell Death Ligand 1 and Tumor-Infiltrating Lymphocytes on Tumor Cells
- (2018) Shaohua Cui et al. Journal of Cancer
- Lung cancer: current therapies and new targeted treatments
- (2017) Fred R Hirsch et al. LANCET
- Adverse prognostic value of PD-L1 expression in primary resected pulmonary squamous cell carcinomas and paired mediastinal lymph node metastases
- (2017) Manuel D Keller et al. MODERN PATHOLOGY
- Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
- (2017) Alice O. Kamphorst et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
- (2017) Zijun Y. Xu-Monette et al. Frontiers in Immunology
- Biomarkers for PD-1/PD-L1 Blockade Therapy in Non–Small-cell Lung Cancer: Is PD-L1 Expression a Good Marker for Patient Selection?
- (2016) Young Kwang Chae et al. Clinical Lung Cancer
- Nivolumab in Combination With Platinum‐Based Doublet Chemotherapy for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer
- (2016) Naiyer A. Rizvi et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictive biomarkers of response to PD-1/PD-L1 immune checkpoint inhibitors in non–small cell lung cancer
- (2016) Kazuhiko Shien et al. LUNG CANCER
- High-mass-resolution MALDI mass spectrometry imaging of metabolites from formalin-fixed paraffin-embedded tissue
- (2016) Alice Ly et al. Nature Protocols
- Multiplatform-based molecular subtypes of non-small-cell lung cancer
- (2016) F Chen et al. ONCOGENE
- Classifying Cancers Based on T-cell Infiltration and PD-L1
- (2015) Michele W.L. Teng et al. CANCER RESEARCH
- High-resolution MALDI-FT-ICR MS imaging for the analysis of metabolites from formalin-fixed, paraffin-embedded clinical tissue samples
- (2015) Achim Buck et al. JOURNAL OF PATHOLOGY
- Detection of metabolites discriminating subtypes of thyroid cancer: Molecular profiling of FFPE samples using the GC/MS approach
- (2015) Anna Wojakowska et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Image analysis of immunohistochemistry is superior to visual scoring as shown for patient outcome of esophageal adenocarcinoma
- (2014) Annette Feuchtinger et al. HISTOCHEMISTRY AND CELL BIOLOGY
- A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer
- (2013) R. J. Kelly et al. ANNALS OF ONCOLOGY
- Analysis of Tissue Specimens by Matrix-Assisted Laser Desorption/Ionization Imaging Mass Spectrometry in Biological and Clinical Research
- (2013) Jeremy L. Norris et al. CHEMICAL REVIEWS
- Deciphering and Reversing Tumor Immune Suppression
- (2013) Greg T. Motz et al. IMMUNITY
- Programmed death ligand-1 expression in non-small cell lung cancer
- (2013) Vamsidhar Velcheti et al. LABORATORY INVESTIGATION
- Links between metabolism and cancer
- (2012) C. V. Dang GENES & DEVELOPMENT
- The DNA damage response and cancer therapy
- (2012) Christopher J. Lord et al. NATURE
- A positive/negative ion–switching, targeted mass spectrometry–based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue
- (2012) Min Yuan et al. Nature Protocols
- Programmed death-1 upregulation is correlated with dysfunction of tumor-infiltrating CD8+ T lymphocytes in human non-small cell lung cancer
- (2010) Yan Zhang et al. Cellular & Molecular Immunology
- Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types
- (2010) M. D. Wilkerson et al. CLINICAL CANCER RESEARCH
- Strategies for discovering novel cancer biomarkers through utilization of emerging technologies
- (2008) Vathany Kulasingam et al. Nature clinical practice. Oncology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More